Cognitive performance related to HIV-1-infected monocytes
about
Exosomes as mediators of neuroinflammationEmerging roles of pericytes in the regulation of the neurovascular unit in health and diseaseThe role of HIV and monocytes/macrophages in adipose tissue biologyHost genetic factors predisposing to HIV-associated neurocognitive disorder.The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and researchSoluble CD163 is associated with shortened telomere length in HIV-infected patients.Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-aMechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesisJAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.Monocytes expand with immune dysregulation and is associated with insulin resistance in older individuals with chronic HIV.Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disordersPeripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognitionSIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS.DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine.Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy.Effects of Cigarette Smoke Condensate on Oxidative Stress, Apoptotic Cell Death, and HIV Replication in Human Monocytic Cells.Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais.Presence of high-risk human papillomavirus genotype and human immunodeficiency virus DNA in anal high-grade and low-grade squamous intraepithelial lesions.Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and ResearchCathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infectionDifferent levels of HIV DNA copy numbers in cerebrospinal fluid cellular subsets.HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment.HIV and neurocognitive dysfunction.Brain mesenchymal stem cells: physiology and pathological implications.Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive DisordersStrategies to limit immune-activation in HIV patients.Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection.Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis.Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy.Mechanisms of CNS Viral Seeding by HIV+ CD14+ CD16+ Monocytes: Establishment and Reseeding of Viral Reservoirs Contributing to HIV-Associated Neurocognitive Disorders.The role of catecholamines in HIV neuropathogenesis.
P2860
Q26865141-7A9354FC-8503-4667-B661-DD7607F9E0ABQ27011505-6B78EEC2-CBCF-4D71-AAA1-89B9ED74FE66Q33608155-05F0BEB4-2BD9-46A2-8AA5-7224AD2F6CE0Q34001122-6C4A51AC-743D-4616-A8BB-4BABFF81B249Q34143299-3301FA6D-435E-4033-B0E3-7DA8581E471AQ34422128-578CB52F-1937-48F0-8003-7FF6469D6904Q34718135-DC2BEC6D-E037-4D85-ACC4-8B4E1CCD3DB3Q34902401-A05E74BD-6240-4339-A619-ED0E2C0EBA67Q35005863-3FC14CBE-A37A-4000-9E73-7828B2A3AE01Q35108968-7FD9AD60-6205-412B-9962-EF88FDBA3283Q35154529-5B13A68C-8850-465A-8B9D-DA36D88EDBD7Q35325801-423AB730-C0CE-48B8-8742-8CBF42C23FD0Q35669020-721213F4-1FAB-424B-B096-D18444C6FFC5Q35895155-06177DC4-30B9-4C26-B828-85A7D63EE061Q35994939-A6096A19-DD26-4330-B046-425C51C91881Q36024121-C180CC4B-BDC5-41E4-87FD-E7ED6189FC8AQ36250020-52C5D989-A473-4ADE-A3EC-6FBCA0AC94D2Q36509615-90015355-E2AF-4501-937F-CDC5059887B0Q36616443-D21AD59D-7582-4F26-ABFB-206C486AD4A4Q36670527-F990BFCE-6183-4E2B-94CB-10B780E03732Q37024994-3FAB1417-45D0-4D69-BAB4-7A6CEB297B9FQ37351669-4EEAFA02-6CA7-4302-A6C0-00FAD4B6CFBFQ37352656-F61FD30F-F598-4D02-B2E4-72EA697385B9Q37720509-7297D4C8-E6B7-4BE6-9A70-C6B6CF845A5FQ38122104-6ECC8F84-18AB-4008-8C43-05FFF9B2FE78Q38858359-173F1485-AACE-414D-8210-87C85754966BQ38948215-77975732-0DFC-40F8-BE85-4435C1CC730AQ38985926-29F416FB-59AB-4411-8D37-CDD8A04DCAFFQ40314419-781720E4-B954-4BA0-99FC-2851C99B85EFQ40354055-D2C308D3-9467-4687-9696-DC4AAF87541DQ42130105-60355E93-AFA6-4317-B05F-4A6ACFDA5C69Q42638904-0D12D02B-64AB-4112-92CE-4F6482A8F2F6Q53828206-85A80C7C-9D18-4BD8-ABC3-CAC9E5CB3FFA
P2860
Cognitive performance related to HIV-1-infected monocytes
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cognitive performance related to HIV-1-infected monocytes
@ast
Cognitive performance related to HIV-1-infected monocytes
@en
type
label
Cognitive performance related to HIV-1-infected monocytes
@ast
Cognitive performance related to HIV-1-infected monocytes
@en
prefLabel
Cognitive performance related to HIV-1-infected monocytes
@ast
Cognitive performance related to HIV-1-infected monocytes
@en
P2093
P2860
P1476
Cognitive performance related to HIV-1-infected monocytes
@en
P2093
Andrew Marshall
Bruce Shiramizu
Cecilia Shikuma
Chin-Yuan Liang
David Troelstrup
John Grove
Melissa Agsalda
Nicholas Whitenack
Van-Nicholas Velasco
P2860
P356
10.1176/APPI.NEUROPSYCH.11050109
P577
2012-01-01T00:00:00Z